Eucomed targets trade barriers in new EU members:
This article was originally published in Clinica
Market access hurdles in Poland and the Czech Republic were among the priorities issues identified by Eucomed's Enlargement Focus Group (ENL) at a meeting on November 18. ENL is concerned in particular about mandatory notification in Poland involving notarised documents and authorised translations. Another issue is the Czech requirement for notarised copies and notification requested for reimbursement purposes. The ENL has also identified as a priority encouraging the realisation of trade agreements between the EU and the second wave entry countries, Bulgaria, Romania and Croatia in medical devices prior to their accession, planned for 2007. These trade agreements are know as PECAs (Protocols to the Europe Agreement on Conformity Assessment and Acceptance of Industrial Products).
You may also be interested in...
Assessment work also isn’t slowing down, the new and generic drug office directors said in an interview, but approval data offers a note of concern.
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.